WHO raises fresh safety concerns about Janssen, AstraZeneca COVID-19 vaccines
The World Health Organisation (WHO), yesterday, raised fresh safety concerns about Janssen and AstraZeneca vaccines.
AstraZeneca searching for vaccines for virus-hit Southeast Asia
Drugmaker AstraZeneca said Saturday it was scouring its supply chain to find more doses of its Covid-19 vaccine for Southeast Asia, which is facing its most serious outbreak yet of the virus. The statement from the Anglo-Swedish company -- which produces its vaccine in Thailand for use domestically and in neighbouring countries -- comes in the…
Rivers State: Mixed feelings, vaccine hesitancy as odds against curbing COVID-19 spread
Chinda Okpara lives in Rumuekini, in Obio Akpor Local Council, one of the largest councils in Rivers State. He has not taken the AstraZeneca-made Coronavirus disease (COVID-19) vaccine...
AstraZeneca cocktail trial fails as Nigeria gets another 3.92m vaccine doses
Vaccine maker, AstraZeneca, yesterday revealed it has hit a setback in trials of a treatment for COVID-19. The drug, made from a combination of two antibodies, failed its main goal to treat coronavirus...
EMA official suggests ditching AstraZeneca jab
A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday. Marco Cavaleri, the EMA's head of vaccine strategy, also told Italy's La Stampa newspaper that the Johnson & Johnson jab should be preferentially used for…
Africa needs 20 mn second AstraZeneca jabs in six weeks
Africa needs at least 20 million doses of the AstraZeneca vaccine within six weeks if those who have had their first shot are to get the second in time, the WHO said Thursday.
EU and AstraZeneca battle in court over vaccine delays
The European Commission will confront drugs giant AstraZeneca in a Belgian court on Wednesday over coronavirus vaccine delivery shortfalls that hampered efforts to kickstart inoculations across the bloc.
EU contract with AstraZeneca on COVID-19 jabs ends June
The European Union has not extended a contract for COVID-19 vaccines with British-Swedish manufacturer AstraZeneca, Internal Market Commissioner, Thierry Breton said on Sunday.
AstraZeneca Covid vaccine sales hit $275 mn in first quarter
British pharmaceuticals giant AstraZeneca said Friday that its Covid vaccine generated $275 million (227 million euros) in sales in the first quarter, as its chief executive defended performance in the face of EU legal action.